Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019

Details for Mechanism ID: 18018
Country/Region: Haiti
Year: 2016
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $290,043 Additional Pipeline Funding: $1,441,573

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $112,330
Testing: HIV Testing and Counseling (HVCT) $99,414
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Treatment: Adult Treatment (HTXS) $78,299
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 142
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 142
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 3,207
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 2,328
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 5,819
HTS_TST Service Delivery Point (Facility): Pediatric 2017 283
HTS_TST Service Delivery Point (Facility): PMTCT 2017 71
HTS_TST Service Delivery Point (Facility): VCT 2017 5,208
HTS_TST Sum of Aggregated Age/Sex <15 2017 284
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 5,535
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 5,819
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 7
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 7
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 117
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 94
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 17,583
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 9,067
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 2,935
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 29,585
PMTCT_ART Already on ART at beginning of current pregnancy 2017 1
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 71
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 1
PMTCT_EID Sum of Infant Age disaggregates 2017 1
PMTCT_STAT By: Known positives at entry 2017 2
PMTCT_STAT Number of new ANC and L&D clients 2017 72
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 71
PMTCT_STAT Sum of Positives Status disaggregates 2017 2
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 19
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 3
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 19
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1
TB_SCREENDX Screen Result: Screened Positive for TB 2017 19
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 605
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 216
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 6
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 4
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 571
TX_CURR Aggregated Age/Sex: <15 Female 2017 6
TX_CURR Aggregated Age/Sex: <15 Male 2017 4
TX_CURR Aggregated Age/Sex: 15+ Female 2017 445
TX_CURR Aggregated Age/Sex: 15+ Male 2017 376
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 831
TX_CURR Sum of Aggregated Age/Sex <15 2017 10
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 821
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 831
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 1
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 1
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 126
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 94
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 221
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 222
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 831
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 625
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 4
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 3
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 334
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 284
TX_PVLS Numerator: Indication: Routine 2017 563
TX_PVLS Numerator: Indication: Targeted 2017 62
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 6
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 4
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 445
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 376
TX_PVLS_den Denominator: Indication: Routine 2017 748
TX_PVLS_den Denominator: Indication: Targeted 2017 83
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 13
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 17
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 10
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
Cross Cutting Budget Categories and Known Amounts Total: $290,043
Key Populations: MSM and TG $250,000
Training of health workers and community outreach workers
Procurement of condoms, lubricants, and other commodities essential to core HIV services for MSM/TG
Key Populations: Sex Workers $40,043
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Procurement of condoms, lubricants, and other commodities essential to core HIV services for SWs